{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:22:07Z","timestamp":1787653327243,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,15]]},"DOI":"10.7759\/cureus.86059","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T13:52:23Z","timestamp":1749995543000},"source":"Crossref","is-referenced-by-count":3,"title":["Balo Concentric Sclerosis: A Rare Variant of Multiple Sclerosis With Excellent Response to Early Steroid Treatment"],"prefix":"10.7759","author":[{"given":"Zhuo","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khan Z","family":"Habiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel V","family":"Narvaez-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton C","year":"2020","unstructured":"Walton C, King R, Rechtman L, et al.. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020, 26:1816-21. 10.1177\/1352458520970841","journal-title":"Mult Scler"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70052-3","article-title":"Balo's concentric sclerosis","volume":"13","author":"Hardy TA","year":"2014","unstructured":"Hardy TA, Miller DH. Balo's concentric sclerosis. Lancet Neurol. 2014, 13:740-6. 10.1016\/S1474-4422(14)70052-3","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1928.02210080044002","article-title":"Encephalitis periaxialis concentrica","volume":"19","author":"Balo J","year":"1928","unstructured":"Balo J. Encephalitis periaxialis concentrica. Arch NeurPsych. 1928, 19:242-64. 10.1001\/archneurpsyc.1928.02210080044002","journal-title":"Arch NeurPsych"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117570","article-title":"Bal\u00f3's concentric sclerosis - a rare entity within the spectrum of demyelinating diseases","volume":"428","author":"Xie JS","year":"2021","unstructured":"Xie JS, Jeeva-Patel T, Margolin E. Bal\u00f3's concentric sclerosis - a rare entity within the spectrum of demyelinating diseases. J Neurol Sci. 2021, 428:117570. 10.1016\/j.jns.2021.117570","journal-title":"J Neurol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12021-5","article-title":"Identification and management of subclinical disease activity in early multiple sclerosis: a review","volume":"271","author":"Ontaneda D","year":"2024","unstructured":"Ontaneda D, Chitnis T, Rammohan K, Obeidat AZ. Identification and management of subclinical disease activity in early multiple sclerosis: a review. J Neurol. 2024, 271:1497-514. 10.1007\/s00415-023-12021-5","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012230","article-title":"Clinical and radiologic features, pathology, and treatment of bal\u00f3 concentric sclerosis","volume":"97","author":"Jolliffe EA","year":"2021","unstructured":"Jolliffe EA, Guo Y, Hardy TA, Morris PP, Flanagan EP, Lucchinetti CF, Tobin WO. Clinical and radiologic features, pathology, and treatment of bal\u00f3 concentric sclerosis. Neurology. 2021, 97:e414-22. 10.1212\/WNL.0000000000012230","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102602","article-title":"Balo's Concentric Sclerosis with monophasic course: a report of 2 cases","volume":"68","author":"Martinez HR","year":"2021","unstructured":"Martinez HR, Rodriguez-Gonzalez IC, Escamilla-Garza JM, Figueroa-Sanchez JA, Garcia-Aleman AC, Hinojosa-Gonzalez DE. Balo's Concentric Sclerosis with monophasic course: a report of 2 cases. Ann Med Surg (Lond). 2021, 68:102602. 10.1016\/j.amsu.2021.102602","journal-title":"Ann Med Surg (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan M","year":"2002","unstructured":"Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002, 58:143-6. 10.1212\/wnl.58.1.143","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14658","article-title":"Ocrelizumab in relapsing and primary progressive multiple sclerosis: pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO","volume":"87","author":"Gibiansky E","year":"2021","unstructured":"Gibiansky E, Petry C, Mercier F, et al.. Ocrelizumab in relapsing and primary progressive multiple sclerosis: pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. Br J Clin Pharmacol. 2021, 87:2511-20. 10.1111\/bcp.14658","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01971-2","article-title":"Heterogeneity of Bal\u00f3's concentric sclerosis: a study of eight cases with different therapeutic concepts","volume":"20","author":"Tzanetakos D","year":"2020","unstructured":"Tzanetakos D, Vakrakou AG, Tzartos JS, et al.. Heterogeneity of Bal\u00f3's concentric sclerosis: a study of eight cases with different therapeutic concepts. BMC Neurol. 2020, 20:400. 10.1186\/s12883-020-01971-2","journal-title":"BMC Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578527","article-title":"Balo concentric sclerosis, an emerging variant of multiple sclerosis: A case-series and literature review","volume":"400","author":"Etemadifar M","year":"2025","unstructured":"Etemadifar M, Aghili A, Shojaei S, Alaei SA, Salari M, Norouzi M. Balo concentric sclerosis, an emerging variant of multiple sclerosis: A case-series and literature review. J Neuroimmunol. 2025, 400:578527. 10.1016\/j.jneuroim.2025.578527","journal-title":"J Neuroimmunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-004-0341-1","article-title":"Marburg type and Bal\u00f2's concentric sclerosis: rare and acute variants of multiple sclerosis","volume":"25 Suppl 4","author":"Capello E","year":"2004","unstructured":"Capello E, Mancardi GL. Marburg type and Bal\u00f2's concentric sclerosis: rare and acute variants of multiple sclerosis. Neurol Sci. 2004, 25 Suppl 4:S361-3. 10.1007\/s10072-004-0341-1","journal-title":"Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2017-0096","article-title":"Balo's concentric sclerosis: an update and comprehensive literature review","volume":"29","author":"Amini Harandi A","year":"2018","unstructured":"Amini Harandi A, Esfandani A, Pakdaman H, Abbasi M, Sahraian MA. Balo's concentric sclerosis: an update and comprehensive literature review. Rev Neurosci. 2018, 29:873-82. 10.1515\/revneuro-2017-0096","journal-title":"Rev Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31823fcd3c","article-title":"CADASIL mutation and Balo concentric sclerosis: a link between demyelination and ischemia?","volume":"78","author":"Chitnis T","year":"2012","unstructured":"Chitnis T, Hollmann TJ. CADASIL mutation and Balo concentric sclerosis: a link between demyelination and ischemia?. Neurology. 2012, 78:221-3. 10.1212\/WNL.0b013e31823fcd3c","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1043-y","article-title":"Bal\u00f3's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures","volume":"15","author":"Jarius S","year":"2018","unstructured":"Jarius S, W\u00fcrthwein C, Behrens JR, Wanner J, Haas J, Paul F, Wildemann B. Bal\u00f3's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures. J Neuroinflammation. 2018, 15:22. 10.1186\/s12974-017-1043-y","journal-title":"J Neuroinflammation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.72.856.10474505","article-title":"MRI features of Balo's concentric sclerosis","volume":"72","author":"Ng SH","year":"1999","unstructured":"Ng SH, Ko SF, Cheung YC, Wong HF, Wan YL. MRI features of Balo's concentric sclerosis. Br J Radiol. 1999, 72:400-3. 10.1259\/bjr.72.856.10474505","journal-title":"Br J Radiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh457","article-title":"Tissue preconditioning may explain concentric lesions in Bal\u00f3's type of multiple sclerosis","volume":"128","author":"Stadelmann C","year":"2005","unstructured":"Stadelmann C, Ludwin S, Tabira T, et al.. Tissue preconditioning may explain concentric lesions in Bal\u00f3's type of multiple sclerosis. Brain. 2005, 128:979-87. 10.1093\/brain\/awh457","journal-title":"Brain"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.23226","article-title":"A review of clinical and imaging findings in tumefactive demyelination","volume":"217","author":"Nakayama M","year":"2021","unstructured":"Nakayama M, Naganawa S, Ouyang M, Jones KA, Kim J, Capizzano AA, Moritani T. A review of clinical and imaging findings in tumefactive demyelination. AJR Am J Roentgenol. 2021, 217:186-97. 10.2214\/AJR.20.23226","journal-title":"AJR Am J Roentgenol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2023.07.006","article-title":"Bruton's tyrosine kinase inhibitors for multiple sclerosis treatment: a new frontier","volume":"42","author":"Greenberg BM","year":"2024","unstructured":"Greenberg BM. Bruton's tyrosine kinase inhibitors for multiple sclerosis treatment: a new frontier. Neurol Clin. 2024, 42:155-63. 10.1016\/j.ncl.2023.07.006","journal-title":"Neurol Clin"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00386","article-title":"Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?","volume":"21","author":"Bourdette D","year":"2024","unstructured":"Bourdette D, Wooliscroft L. Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?. Neurotherapeutics. 2024, 21:e00386. 10.1016\/j.neurot.2024.e00386","journal-title":"Neurotherapeutics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/379976-balo-concentric-sclerosis-a-rare-variant-of-multiple-sclerosis-with-excellent-response-to-early-steroid-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T13:52:24Z","timestamp":1749995544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/379976-balo-concentric-sclerosis-a-rare-variant-of-multiple-sclerosis-with-excellent-response-to-early-steroid-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.86059","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,15]]}}}